Roche Media Nov 3, 2025 Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena #Phase III #III trial
Roche Media Nov 3, 2025 Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold - BioSpace #Barrier Tech #Roche Piles
Roche Media Nov 3, 2025 Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win - Fierce Pharma #Roche Gazyva #Fierce Pharma
Roche Media Nov 3, 2025 Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain - Fierce Biotech #Manifold Bio #Fierce Biotech
Roche Media Nov 3, 2025 Roche taps an AI specialist to craft new brain drugs - BioPharma Dive #Roche taps #BioPharma Dive
Thermo Fisher Nov 3, 2025 How Investors Are Reacting To Thermo Fisher Scientific (TMO) Product Launches and Strong Quarterly Results - simplywall.st #Fisher Scientific #Product Launches
Thermo Fisher Nov 3, 2025 Thermo Fisher Scientific Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily #Price Performance #Fisher Scientific
Illumina Nov 2, 2025 Illumina (ILMN) Soars 23.4% on Earnings Beat - Yahoo Finance #Earnings Beat #Yahoo Finance
Waters Nov 2, 2025 Waters Corporation (WAT) Q3 Earnings: What To Expect - Markets Financial Content #Waters Corporation #Markets Financial
Thermo Fisher Nov 2, 2025 Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario - MedCity News #Fisher Expands #Expands Biopharma
Thermo Fisher Nov 2, 2025 Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years - Yahoo Finance #Fisher Scientific #Thermo Fisher
Roche Media Nov 1, 2025 Manifold Bio Announces Strategic Collaboration with Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases - Business Wire #Bio Announces #Announces Strategic
Illumina Nov 1, 2025 Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq #Maintains Illumina #Underweight Recommendation
Illumina Nov 1, 2025 Illumina (ILMN) Returns to Profitability, Undervalued Versus Peers but Growth Lags Market - Yahoo Finance #Undervalued Versus #Versus Peers
Agilent Nov 1, 2025 Agilent Technologies (A): Evaluating Valuation as New CFO Adam Elinoff Joins to Drive Strategic Transformation - Yahoo Finance #Evaluating Valuation #CFO Adam
Promega Blog Oct 31, 2025 Bones and Blood: Uncovering History Through DNA #Halloween serves #DNA Halloween